<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font17 { font-size : 17; } .font19 { font-size : 19; } .font23 { font-size : 23; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">vaccine </span>
   <span class="font23">vaccines </span>
   <span class="font19">[]. </span>
   <span class="font17">[accessed </span>
   <span class="font16">February </span>
   <span class="font16">Health </span>
   <span class="font16">immunization </span>
   <span class="font16">research </span>
   <span class="font15">[], </span>
   <span class="font15">development </span>
   <span class="font15">influenza </span>
   <span class="font15">GVIRF </span>
   <span class="font15">Global </span>
   <span class="font15">World </span>
   <span class="font14">Vaccine </span>
   <span class="font14">new </span>
   <span class="font14">{border-style </span>
   <span class="font14">health </span>
   <span class="font14">participants </span>
   <span class="font14">px;} </span>
   <span class="font14">#ffffff;} </span>
   <span class="font14">Dr. </span>
   <span class="font14">Organization. </span>
   <span class="font14">human </span>
   <span class="font13">global </span>
   <span class="font13">countries </span>
   <span class="font13">disease </span>
   <span class="font13">efficacy </span>
   <span class="font12">Research </span>
   <span class="font12">virus </span>
   <span class="font12">Action </span>
   <span class="font12">improve </span>
   <span class="font12">infection </span>
   <span class="font12">regulatory </span>
   <span class="font12">studies </span>
   <span class="font12">capacity </span>
   <span class="font12">children </span>
   <span class="font12">poliovirus </span>
   <span class="font12">use </span>
   <span class="font12">value </span>
   <span class="font12">Immunization </span>
   <span class="font12">access </span>
   <span class="font12">clinical </span>
   <span class="font12">diseases </span>
   <span class="font12">high </span>
   <span class="font12">national </span>
   <span class="font12">polio </span>
   <span class="font12">type </span>
   <span class="font12">used </span>
   <span class="font11">HIV </span>
   <span class="font11">Press; </span>
   <span class="font11">address </span>
   <span class="font11">approach </span>
   <span class="font11">delivery </span>
   <span class="font11">described </span>
   <span class="font11">impact </span>
   <span class="font11">malaria </span>
   <span class="font11">needed </span>
   <span class="font11">potential </span>
   <span class="font11">provide </span>
   <span class="font11">px; </span>
   <span class="font11">target </span>
   <span class="font11">{font-family </span>
   <span class="font11">Forum </span>
   <span class="font11">Vaccines </span>
   <span class="font11">approaches </span>
   <span class="font11">challenges </span>
   <span class="font11">developing </span>
   <span class="font11">facilitate </span>
   <span class="font11">font-size </span>
   <span class="font11">immunization. </span>
   <span class="font11">million </span>
   <span class="font11">pandemic </span>
   <span class="font11">primary </span>
   <span class="font11">protection </span>
   <span class="font11">public </span>
   <span class="font11">vaccines. </span>
   <span class="font11">GVIRF, </span>
   <span class="font11">Infect </span>
   <span class="font11">March </span>
   <span class="font11">OPV </span>
   <span class="font11">analysis </span>
   <span class="font11">available </span>
   <span class="font11">double; </span>
   <span class="font11">expected </span>
   <span class="font11">hookworm </span>
   <span class="font11">implementation </span>
   <span class="font11">improving </span>
   <span class="font11">innovation </span>
   <span class="font11">manufacturers </span>
   <span class="font11">observed </span>
   <span class="font11">pipeline </span>
   <span class="font11">pneumococcal </span>
   <span class="font11">prevent </span>
   <span class="font11">product </span>
   <span class="font11">products </span>
   <span class="font11">results </span>
   <span class="font11">risk </span>
   <span class="font11">robust </span>
   <span class="font11">rotavirus </span>
   <span class="font11">significant </span>
   <span class="font11">support </span>
   <span class="font11">trial </span>
   <span class="font11">universal </span>
   <span class="font11">vaccines, </span>
   <span class="font11">(GVIRF), </span>
   <span class="font11">(NCT). </span>
   <span class="font11">Blueprint </span>
   <span class="font11">CHIMs </span>
   <span class="font11">Group </span>
   <span class="font11">Indiaâ€™s </span>
   <span class="font11">National </span>
   <span class="font11">Phase </span>
   <span class="font11">Plan </span>
   <span class="font11">RSV </span>
   <span class="font11">additional </span>
   <span class="font11">alternative </span>
   <span class="font11">antimicrobial </span>
   <span class="font11">benefits </span>
   <span class="font11">border-color </span>
   <span class="font11">border-width </span>
   <span class="font11">candidates </span>
   <span class="font11">conjugate </span>
   <span class="font11">contribute </span>
   <span class="font11">controlled </span>
   <span class="font11">countries. </span>
   <span class="font11">coverage </span>
   <span class="font11">data </span>
   <span class="font11">doses </span>
   <span class="font11">focus </span>
   <span class="font11">highlighted </span>
   <span class="font11">identify </span>
   <span class="font11">including </span>
   <span class="font11">infectious </span>
   <span class="font11">mAb </span>
   <span class="font11">mAbs </span>
   <span class="font11">maternal </span>
   <span class="font11">meeting </span>
   <span class="font11">model </span>
   <span class="font11">mortality </span>
   <span class="font11">plan </span>
   <span class="font11">populations </span>
   <span class="font11">prevention </span>
   <span class="font11">progress </span>
   <span class="font11">responses </span>
   <span class="font11">social </span>
   <span class="font11">solid; </span>
   <span class="font11">study </span>
   <span class="font11">systems </span>
   <span class="font11">targeting </span>
   <span class="font11">technology </span>
   <span class="font11">underway </span>
   <span class="font11">using </span>
   <span class="font11">{font-style </span>
   <span class="font11">{font-weight </span>
   <span class="font10">Bangkok, </span>
   <span class="font10">Dis </span>
   <span class="font10">GVAP </span>
   <span class="font10">Human </span>
   <span class="font10">India </span>
   <span class="font10">Mission </span>
   <span class="font10">Polio </span>
   <span class="font10">Thailand. </span>
   <span class="font10">U.S. </span>
   <span class="font10">achieve </span>
   <span class="font10">antibodies </span>
   <span class="font10">bold </span>
   <span class="font10">booster </span>
   <span class="font10">called </span>
   <span class="font10">child </span>
   <span class="font10">complex </span>
   <span class="font10">control </span>
   <span class="font10">countries, </span>
   <span class="font10">courier; </span>
   <span class="font10">crucial </span>
   <span class="font10">demonstrated </span>
   <span class="font10">development, </span>
   <span class="font10">effective </span>
   <span class="font10">em; </span>
   <span class="font10">emerging </span>
   <span class="font10">epidemic </span>
   <span class="font10">eradication, </span>
   <span class="font10">half </span>
   <span class="font10">hepatitis </span>
   <span class="font10">immune </span>
   <span class="font10">immunity </span>
   <span class="font10">infants </span>
   <span class="font10">leading </span>
   <span class="font10">licensure, </span>
   <span class="font10">low </span>
   <span class="font10">manufacturing </span>
   <span class="font10">media </span>
   <span class="font10">multiple </span>
   <span class="font10">number </span>
   <span class="font10">operational </span>
   <span class="font10">opportunities </span>
   <span class="font10">passive </span>
   <span class="font10">poor </span>
   <span class="font10">pregnant </span>
   <span class="font10">programs </span>
   <span class="font10">protein </span>
   <span class="font10">providing </span>
   <span class="font10">pt;} </span>
   <span class="font10">reduce </span>
   <span class="font10">regional </span>
   <span class="font10">remains </span>
   <span class="font10">require </span>
   <span class="font10">resistance </span>
   <span class="font10">strategies </span>
   <span class="font10">strong </span>
   <span class="font10">sustained </span>
   <span class="font10">testing </span>
   <span class="font10">time </span>
   <span class="font10">treatment </span>
   <span class="font10">vaccination </span>
   <span class="font10">vaccination. </span>
   <span class="font10">vaccine, </span>
   <span class="font10">vaccine-derived </span>
   <span class="font10">vectors </span>
   <span class="font10">vitro </span>
   <span class="font10">years, </span>
  </p>
 </body>
</html>
